Idarucizumab for a traumatic head injury patient taking dabigatran

BACKGROUND: Dabigatran is one of the four drugs currently used as a direct oral anticoagulant in Japan. Idarucizumab, which specifically targets dabigatran, was recently approved in Japan. We present a case of intracranial hemorrhage in a traumatic brain injury patient taking dabigatran who was trea...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Emerg Med
Prif Awduron: Maruyama, Shuhei, Hayakawa, Koichi, Kanayama, Shuji, Iwamura, Hiromu, Wada, Daiki, Saito, Fukuki, Nakamori, Yasushi, Kuwagata, Yasuyuki
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2018
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6326148/
https://ncbi.nlm.nih.gov/pubmed/31179930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12245-018-0202-y
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg